Total planned funding: $178,612,748
Allocations
Countries/Regions
Eswatini | $178,612,748 |
Organizational Types
Private Contractor | $41,544,899 |
University | $40,953,749 |
NGO | $38,352,073 |
Own Agency | $23,900,119 |
Unknown | $21,380,842 |
Host Country Government Agency | $7,753,560 |
Other USG Agency | $1,891,166 |
Multi-lateral Agency | $1,503,840 |
FBO | $742,500 |
Implementing Agency | $590,000 |
Program Areas
Care | $58,859,393 |
Prevention | $33,895,912 |
Treatment | $32,359,596 |
Governance and Systems | $26,733,471 |
Management and Operations | $15,958,403 |
Testing | $10,805,973 |
Budget Codes
HBHC: Care: Adult Care and Support | $25,599,199 |
HTXS: Treatment: Adult Treatment | $25,062,335 |
HVMS: Management and Operations | $15,958,403 |
HKID: Care: Orphans and Vulnerable Children | $15,530,050 |
HVTB: Care: TB/HIV | $12,132,897 |
HVSI: Strategic Information | $11,369,738 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $11,132,400 |
HVCT: Testing: HIV Testing and Counseling | $10,805,973 |
OHSS: Health Systems Strengthening | $10,267,682 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $8,716,306 |
HVOP: Sexual Prevention: Other Sexual Prevention | $7,651,863 |
PDCS: Care: Pediatric Care and Support | $5,597,247 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $5,205,343 |
HLAB: Laboratory Infrastructure | $5,096,051 |
PDTX: Treatment: Pediatric Treatment | $4,298,113 |
HTXD: Treatment: ARV Drugs | $2,999,148 |
HMBL: Biomedical Prevention: Blood Safety | $1,190,000 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Columbia University:
$38,083,358
Countries/Regions
Pact, Inc.:
$22,281,978
Countries/Regions
Not Available:
$21,230,842
Countries/Regions
USG Aggregated Agencies:
$14,983,192
Countries/Regions